Anti-chlamydial methods and materials
AssigneeXoma Corporation
InventorLewis H. Lambert, Jr.
Life of this patent
Estimating the term…
Abstract
The present invention relates to methods for treating chlamydial infection comprising administering to a subject suffering from a chlamydial infection a bactericidal permeability-inducing (BPI) protein product.
Claims18
A method of treating chlamydial infections comprising concurrent administration to a subject suffering from a chlamydial infection of a bactericidal/permeability-increasing (BPI) protein product and a non-BPI anti-chlamydial agent effective to treat the chlamydial infection.
A method of killing or inhibiting replication of chlamydia comprising concurrent contacting of the chlamydia with a bactericidal/permeability-increasing (BPI) protein product and a non-BPI anti-chlamydial agent, wherein the non-BPI anti-chlamydial agent is a tetracycline, a macrolide, a quinolone, chloramphenicol, rifampin, clindamycin or a sulfonamide.
Dependencies are inferred from the claim text.